Quest PharmaTech Inc.
QPTFF
$0.02
-$0.01-33.33%
OTC PK
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -19.09% | 24.71% | -23.08% | 14.21% | -47.52% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -25.49% | -3.51% | -13.11% | -3.06% | -25.32% |
| Operating Income | 25.49% | 3.51% | 13.11% | 3.06% | 25.32% |
| Income Before Tax | 310.33% | 2,959.84% | -124.40% | 177.03% | 18.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 310.33% | 2,959.84% | -124.40% | 177.03% | 18.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 310.33% | 2,959.84% | -124.40% | 177.03% | 18.67% |
| EBIT | 25.49% | 3.51% | 13.11% | 3.06% | 25.32% |
| EBITDA | -- | -- | -- | -- | 25.51% |
| EPS Basic | 311.43% | 2,200.00% | -125.81% | 176.32% | 19.54% |
| Normalized Basic EPS | 331.25% | 514.29% | -155.56% | 100.00% | 11.11% |
| EPS Diluted | 311.43% | 2,200.00% | -125.81% | 176.32% | 19.54% |
| Normalized Diluted EPS | 331.25% | 514.29% | -155.56% | 100.00% | 11.11% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |